These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3444173
1. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy]. Matsuda H, Sakashita S, Arakawa M, Koyanagi T. Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173 [No Abstract] [Full Text] [Related]
2. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma. Kalin B, Jacobsson H. Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278 [No Abstract] [Full Text] [Related]
3. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases. Garcia JR, Simo M, Perez G, Soler M, Lopez S, Setoain X, Lomeña F. Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662 [No Abstract] [Full Text] [Related]
5. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma. Rudberg U, Udén R, Ahlbäck SO. Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417 [Abstract] [Full Text] [Related]
6. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer]. Otsuka N, Fukunaga M, Morita R, Sone T, Yoneda M, Saito N, Tanaka H, Tomomitsu T, Yanagimoto S, Muranaka A. Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922 [No Abstract] [Full Text] [Related]
7. Tracheal uptake on Tc-99m MDP bone scintigraphy can be a potential source of false-positive results in a prostate cancer patient. Sood A, Sethi S, Kumar R. Clin Nucl Med; 2010 Jun; 35(6):454-5. PubMed ID: 20479601 [No Abstract] [Full Text] [Related]
8. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma. Sundkvist GM, Ahlgren L, Lilja B, Mattsson S. Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355 [Abstract] [Full Text] [Related]
9. [New criteria for scintigraphic follow-up of bone metastases following radiotherapy. Results of functional scintigraphy using 99mTc-MDP]. Knop J, Stritzke P, Langendorff G. Nuklearmedizin; 1985 Dec; 24(5-6):238-43. PubMed ID: 4094901 [Abstract] [Full Text] [Related]
11. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP. Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W. Hell J Nucl Med; 2017 Dec; 20(3):237-240. PubMed ID: 29177262 [Abstract] [Full Text] [Related]
14. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy]. Suto Y, Tanigawa N, Iwamiya T, Kato T, Endo K, Shabana M, Ohta Y. Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug 25; 53(8):953-9. PubMed ID: 8396760 [Abstract] [Full Text] [Related]
16. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL, Xue YL, Song HJ, Luo QY. Nucl Med Commun; 2012 Dec 25; 33(12):1232-42. PubMed ID: 23111353 [Abstract] [Full Text] [Related]